1-3 of 3
Jeanette H. W. Leusen, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glycoengineered CD20 Antibody Obinutuzumab Activates Neutrophils and Mediates Phagocytosis Through CD16B More Efficiently Than Rituximab

Josée Golay, PhD, Fabio Da Roit, BSc, Luca Bologna, BSc, Claudia Ferrara Koller, PhD, Jeanette H. W. Leusen, PhD, Alessandro Rambaldi, MD, Christian Klein, PhD, Martino Introna, MD
Journal: Blood
Blood (2013) 122 (21): 4419.
https://doi.org/10.1182/blood.V122.21.4419.4419
Published: 2013
Journal Articles

Daratumumab, a Human CD38 Antibody Induces Apoptosis of Myeloma Tumor Cells Via Fc Receptor-Mediated Crosslinking.

J. H. Marco Jansen, Peter Boross, PhD, Marije B. Overdijk, PhD student, Jeroen J. Lammerts van Bueren, PhD, Paul W.H.I. Parren, PhD, Jeanette H. W. Leusen, PhD
Journal: Blood
Blood (2012) 120 (21): 2974.
https://doi.org/10.1182/blood.V120.21.2974.2974
Published: 2012
Journal Articles

Recombinant Dimeric IgA Antibodies as Tumor-Specific Agents.

Michael Dechant, MD, Stefan Lohse, PhD, Stefanie Derer, PhD, Thomas Beyer, PhD, Katja Klausz, PhD, Matthias Peipp, PhD, Jeanette H. W. Leusen, PhD, Jan G. J. van de Winkel, PhD, Thomas Valerius, MD
Journal: Blood
Blood (2010) 116 (21): 1488.
https://doi.org/10.1182/blood.V116.21.1488.1488
Published: 2010